Commodore Capital LP Nkarta, Inc. Call Options Transaction History
Commodore Capital LP
- $1.12 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NKTX
# of Institutions
126Shares Held
67.1MCall Options Held
142KPut Options Held
43.1K-
Ra Capital Management, L.P. Boston, MA10.8MShares$34.5 Million0.96% of portfolio
-
Boxer Capital, LLC San Diego, CA5.61MShares$17.9 Million1.84% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$12.9 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.8MShares$12.1 Million0.47% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$12 Million11.45% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $155M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...